PRD Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8.77M
- Investors
-
8
PRD Therapeutics General Information
Description
Operator of a drug discovery company intended to develop medicines for metabolic diseases. The company's software focuses on the development of first-in-class oral medications using selective inhibitors for the treatment of homozygous familial hypercholesterolemia and metabolic dysfunction-associated steatotic liver disease, utilizing specific compounds to reduce the burden of treatment for patients and families while improving health outcomes, enabling medical professionals to provide advanced therapeutic options for complex metabolic conditions.
Contact Information
Website
www.prdtherapeutics.comCorporate Office
- 1506, Kitasato University Shirokane Campus
- 5-9-1 Shirokane, Minato-ku
- Tokyo, Minato-ku 108-0072
- Japan
Corporate Office
- 1506, Kitasato University Shirokane Campus
- 5-9-1 Shirokane, Minato-ku
- Tokyo, Minato-ku 108-0072
- Japan
PRD Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 06-Oct-2023 | $8.77M | Completed | Clinical Trials - General | ||
| 3. Seed Round | 27-Apr-2022 | Completed | Clinical Trials - General | |||
| 2. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 1. Accelerator/Incubator | Completed | Clinical Trials - General |
PRD Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
PRD Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PRD Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PRD Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jafco | Venture Capital | Minority | ||
| Japan Growth Investments Alliance | Growth/Expansion | Minority | ||
| JIC Venture Growth Investments | Venture Capital | Minority | ||
| Mizuho | Corporation | Minority | ||
| SMBC Venture Capital | Corporate Venture Capital | Minority |
PRD Therapeutics FAQs
-
When was PRD Therapeutics founded?
PRD Therapeutics was founded in 2021.
-
Where is PRD Therapeutics headquartered?
PRD Therapeutics is headquartered in Tokyo, Japan.
-
What is the size of PRD Therapeutics?
PRD Therapeutics has 3 total employees.
-
What industry is PRD Therapeutics in?
PRD Therapeutics’s primary industry is Drug Discovery.
-
Is PRD Therapeutics a private or public company?
PRD Therapeutics is a Private company.
-
What is PRD Therapeutics’s current revenue?
The current revenue for PRD Therapeutics is .
-
How much funding has PRD Therapeutics raised over time?
PRD Therapeutics has raised $9.2M.
-
Who are PRD Therapeutics’s investors?
Jafco, Japan Growth Investments Alliance, JIC Venture Growth Investments, Mizuho, and SMBC Venture Capital are 5 of 8 investors who have invested in PRD Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
